Clinical trial

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

NCT06944470

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-05-20

PhasePHASE2

Study timeline

Study start (actual)2025-05-20Date precision: day

Registry last updated2026-07-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLCunresolved

Interventions

Paclitaxel + Carboplatin/cisplatin for squamous cell carcinoma and pemetrexed + carboplatin/cisplatin for non-squamous cell carcinomaDRUG

surgeryPROCEDURE

RadiochemotherapyRADIATION

JS207DRUG

Sponsors & collaborators

Shanghai Junshi Bioscience Co., Ltd.lead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06944470 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.